Clinique médicale l'Actuel,

Montreal, Quebec H2l 4P9

0 studies enrolling now · 6 studies all time

What they study most

Acquired Immunodeficiency Syndrome, HIV Infection, HIV Infections, HIV-1, HIV-1 Infection, Lipodystrophy

Studies at this site

• Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults — Completed
• Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed
• Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults — Completed
• TH9507 in Patients With HIV-Associated Lipodystrophy — Completed
• A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy — Stopped early